AIRIS 2024: Global Cooperation A Challenge For Regulation Of AI Products

Certainty And Clarity Key Issues For Industry

During the first international symposium on the use of AI in medical products, co-hosted by US and Korean regulators, global experts discussed issues and challenges related to effective development and regulation. Cooperation, flexibility and the need for a "human-centric" approach emerged as key themes in the fast-moving field.

AIRIS 2024
Regulators Should Pursue Alignment Of Expectations, Harmonized, Consensus Standards • Source: Jung Won Shin

Cutting-edge digital technologies, such as generative artificial intelligence (AI), are rapidly becoming embedded into people's daily lives, while in the health and medical field AI technology is increasingly being actively applied to the development of new drugs and medical devices.

More from South Korea

More from Asia